Home > Eureka Therapeutics Salary

Eureka Therapeutics Salary

  • 89
  • 44
  • 62
Eureka Therapeutics average salary is $77,310, median salary is $72,323 with a salary range from $70,992 to $93,600.
Eureka Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Eureka Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
70,992
Average
77,310
Median
72,323
High
93,600
Total 4 Eureka Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Software Engineer 73,653-73,653 Dayton, OH, 45401 2018 Eureka Therapeutics Software Engineer Salaries (3)
Eureka Therapeutics Dayton, OH Salaries
Software Engineer 70,992-70,992 Dayton, OH, 45401 2017 Eureka Therapeutics Software Engineer Salaries (3)
Eureka Therapeutics Dayton, OH Salaries
Software Engineer 70,992-70,992 Dayton, OH, 45401 2016 Eureka Therapeutics Software Engineer Salaries (3)
Eureka Therapeutics Dayton, OH Salaries
Computer Programmer 93,600-93,600 Dayton, OH, 45401 2014 Eureka Therapeutics Computer Programmer Salaries (1)
Eureka Therapeutics Dayton, OH Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Eureka Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Eureka Therapeutics Jobs
See more Eureka Therapeutics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Eureka Therapeutics... Information
  • Eureka Therapeutics Inc
  • Industry: BioTech/Drugs
  • City: Emeryville, CA
  • Eureka Therapeutics, Inc. is a privately-owned, venture capital-funded biotechnology company headquartered in Emeryville, California. Eureka provides a range of services and products to partner companies pursuing therapeutic antibody treatments for disease. Our primary technology involves the enhancement of the ADCC activity of human (or humanized) antibodies to improve their clinical efficacy. Currently, Eureka has one US research facility dedicated to technology innovation and service provision, and one Chinese subsidiary in Beijing for carrying out preclinical and clinical studies.